Myrtelle Announces Presentation of Positive 6-month Post-Treatment Data in Its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the American Society of Gene and Cell Therapy 26th Annual Meeting
Wakefield, Mass., May, 16th, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
May 16, 2023
This article is featured on another website.
Go to article
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…